Historical record - last NADAC publication: 2/19/2020
Product Information
PIOGLITAZONE-METFORMIN 15-850 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.5877 per EA under NDC 57237021881. Its NADAC has been published 133 times since Aug 9, 2017.
Strength
850; 15 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237021881
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/19/2020
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200823On Market Since
2/13/2013
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-METFORMIN 15-850 has been published 133 times since Aug 9, 2017, and over the history we have for it it has declined 48.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.5877 per EA |
|---|---|
| All-time high | $1.1649 (Sep 13, 2017) |
| All-time low | $0.5567 (Jan 22, 2020) |
| Median price | $0.8445 |
| Average price | $0.8564 |
| Largest weekly change | +30.3% (Jul 18, 2018) |
| Weeks tracked | 133 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 50% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-METFORMIN 15-850?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-850, manufactured by Rising Pharma Holdings Inc., is $0.5877 per EA (NDC 57237021881), effective Feb 19, 2020.
How has the price of PIOGLITAZONE-METFORMIN 15-850 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has declined 48.7%. It has been tracked across 133 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-850?
Since Aug 9, 2017, the NADAC for PIOGLITAZONE-METFORMIN 15-850 has ranged from a low of $0.5567 (Jan 22, 2020) to a high of $1.1649 (Sep 13, 2017), with a median of $0.8445 per EA.
Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-850?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PIOGLITAZONE-METFORMIN 15-850, is $0.2932 per EA — about 50% below PIOGLITAZONE-METFORMIN 15-850.
Who manufactures PIOGLITAZONE-METFORMIN 15-850?
PIOGLITAZONE-METFORMIN 15-850 (NDC 57237021881) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification